Rimas J. Orentas
Miltenyi Biotec (Germany)(DE)Lentigen Technology (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Virus-based gene therapy research, Neuroblastoma Research and Treatments
Most-Cited Works
- → T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial(2014)2,912 cited
- → 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors(2015)1,752 cited
- → CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy(2017)1,320 cited
- → CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors(2019)650 cited
- → Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia(2012)580 cited
- → Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial(2020)443 cited